产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 药品制剂 Clindamycin Pho...

Clindamycin Phosphate for Injection

2025-02-07
成都市

产品详情

Clindamycin Phosphate for Injection
抗菌药与抗病毒药制剂
Clindamycin Phosphate for Injection
中/南美洲,东欧,亚洲,中东,非洲

产品描述

Active ingredients: clindamycin phosphate.

Description: white or off-white cake or powder.

Dosage Form: lyophilized powder for injection.
Strength: (1) o.3g; (2) 0.6g (Calculated by C18H33ClN2O5S).
Indications:

1. For the treatment of a variety of infectious diseases caused by gram-positive bacteria.

2. For the treatment of a variety of infectious diseases caused by anaerobic bacteria.

Storage: Keep airtight in a cool place at a temperature not above 20 ℃, protect from light.

Packaging: tubular vial for antibiotic use, 10 bottles/box; 1 bottle/box; 5 bottles/box (Can be customized based on customer's order.)
Shelf Life: 24 months

Dosage and Administration:

It is administrated as a slow intravenous infusion. Before use, add the powder (0.3g) into 50 to 100ml of normal saline or 5% glucose solution for dilution, liquid concentration is less than 6mg/ml, usually, the rate is not exceeded 20mg per minute.

剂型
Dosage Form

生产线(条)
Poduction Lines

年产能
Annual Capacity 

注射剂
Injection

8

650,000,000

口服固体制剂
Oral Solid

3

700,000,000

原料药和中间体
API & Intermediates

3

8,000 Kg

中药前处理和提取
TCM Extraction

2

5,000,000 Kg 

Baiyu provide CDMO service for:

FDFs & APIs
Primary & secondary packaging
Warehousing
Commercial scale, pilot scale, laboratory scale

You are warmly welcomed to contact us for business cooperation.

sales@baiyu.cn

www.baiyujituan.com

四川宏明博思药业有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

四川宏明博思药业有限公司成立于2013年,专注于原料药和制剂的生产。现有员工400余人,主要生产高端剂型如注射剂、冻干粉针剂、片剂和胶囊剂。宏明博思的冻干粉针制剂生产线已获得EU GMP,并通过巴西ANVISA现场检查。目前四川宏明博思冻干粉针制剂的多个产品在巴西、智利、秘鲁、危地马拉、泰国、菲律宾、马来西亚、南非、澳大利亚等开展注册中。Sichuan Omnis Pharmaceutical Co., Ltd. was established in 2013, focusing on the manufacture of FDFs and APIs, located in Sichuan Chengdu, China. It currently has more than 400 employees and mainly produces high-end dosage forms such as injections, lyophilized powder injections, tablets and capsules. Omnis has granted China/EU/ANVISA/PICs GMP for lyophilized powder injection line. Currently, multiple products of lyophilized powder injection are undergoing registration in Brazil, Chile, Peru, Guatemala, Thailand, the Philippines, Malaysia, South Africa, Australia, and other countries.
业务类型:
成立日期:
年营业额:
主营产品类别: